PubRank

F H Glorieux

Author PubWeight™ 149.52‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987 24.27
2 LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001 11.99
3 Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 2001 2.87
4 Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. Proc Natl Acad Sci U S A 1976 2.59
5 Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. Endocrinology 2000 2.08
6 Osteoblasts isolated from mouse calvaria initiate matrix mineralization in culture. J Cell Biol 1983 1.80
7 Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia. N Engl J Med 1995 1.78
8 Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease. Bone 2002 1.77
9 Linkage disequilibrium analysis in young populations: pseudo-vitamin D-deficiency rickets and the founder effect in French Canadians. Am J Hum Genet 1996 1.68
10 Perinatal metabolism of vitamin D. Am J Clin Nutr 2000 1.67
11 Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age. J Clin Endocrinol Metab 2000 1.65
12 Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP). Hum Mol Genet 1997 1.64
13 Mepe, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone. Genomics 2001 1.60
14 The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J Bone Miner Res 1997 1.53
15 Replacement therapy for inherited enzyme deficiency: liver orthotopic transplantation in Niemann-Pick disease type A. Am J Med Genet 1977 1.51
16 Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone 2000 1.46
17 Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia. N Engl J Med 1972 1.46
18 Renal handling of phosphate in vivo and in vitro by the X-linked hypophosphatemic male mouse: evidence for a defect in the brush border membrane. Kidney Int 1978 1.45
19 cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone. Genomics 1996 1.41
20 Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. N Engl J Med 1980 1.37
21 Collagen changes in the human uterine cervix at parturition. Am J Obstet Gynecol 1978 1.30
22 Relation between hypomineralized periosteocytic lesions and bone mineralization in vitamin D-resistant rickets. Calcif Tissue Int 1983 1.30
23 Vitamin D supplementation during pregnancy: effect on neonatal calcium homeostasis. J Pediatr 1986 1.29
24 Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study. J Clin Endocrinol Metab 2010 1.22
25 Osteogenesis imperfecta--clinical and molecular diversity. Eur Cell Mater 2003 1.20
26 The mineralization density of iliac crest bone from children with osteogenesis imperfecta. Calcif Tissue Int 1999 1.19
27 Polymerase chain reaction-based technique for the selective enrichment and analysis of mosaic arg201 mutations in G alpha s from patients with fibrous dysplasia of bone. Bone 1997 1.16
28 X-linked hypophosphatemia: effect of calcitriol on renal handling of phosphate, serum phosphate, and bone mineralization. J Clin Endocrinol Metab 1981 1.15
29 Structural and cellular changes during bone growth in healthy children. Bone 2000 1.11
30 Correction of the abnormal mineral ion homeostasis with a high-calcium, high-phosphorus, high-lactose diet rescues the PDDR phenotype of mice deficient for the 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1). Bone 2003 1.08
31 Engineering bone regeneration with bioabsorbable scaffolds with novel microarchitecture. Tissue Eng 1999 1.07
32 Lumbar bone mineral content measured by dual energy X-ray absorptiometry in newborns and infants. Acta Paediatr 1992 1.05
33 Hypoparathyroidism during pregnancy: treatment with calcitriol. J Clin Endocrinol Metab 1981 1.03
34 Thirty-three novel COL1A1 and COL1A2 mutations in patients with osteogenesis imperfecta types I-IV. Hum Mutat 2001 1.02
35 Temporal and spatial expression of bone morphogenetic protein-2, -4, and -7 during distraction osteogenesis in rabbits. Bone 2000 1.00
36 Linkage mapping by simultaneous screening of multiple polymorphic loci using Alu oligonucleotide-directed PCR. Proc Natl Acad Sci U S A 1992 0.99
37 CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII. Bone 2009 0.99
38 The bone formation defect in idiopathic juvenile osteoporosis is surface-specific. Bone 2002 0.99
39 X-linked hypophosphataemic rickets: Inadequate therapeutic response to 1,25-dihydroxycholecalciferol. Lancet 1973 0.98
40 Bone-specific expression of the alpha chain of the nascent polypeptide-associated complex, a coactivator potentiating c-Jun-mediated transcription. Mol Cell Biol 1998 0.98
41 Osteogenesis imperfecta at the beginning of bone and joint decade. Croat Med J 2001 0.98
42 Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets. Calcif Tissue Int 1981 0.96
43 In vitro metabolism of 25-hydroxycholecalciferol by isolated cells from human decidua. J Clin Endocrinol Metab 1985 0.96
44 Control of vitamin D metabolism in preterm infants: feto-maternal relationships. Arch Dis Child 1982 0.96
45 Deficient bone formation in idiopathic juvenile osteoporosis: a histomorphometric study of cancellous iliac bone. J Bone Miner Res 2000 0.96
46 Effect of dietary phosphate deprivation and supplementation of recipient mice on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice. J Bone Miner Res 1992 0.96
47 Normative data on mineralization density distribution in iliac bone biopsies of children, adolescents and young adults. Bone 2009 0.96
48 Dual energy x-ray absorptiometry measurement of bone mineral content in newborns: validation of the technique. Pediatr Res 1992 0.95
49 Resolution of severe, adolescent-onset hypophosphatemic rickets following resection of an FGF-23-producing tumour of the distal ulna. Bone 2004 0.94
50 Vitamin D dependency: replacement therapy with calcitriol? J Pediatr 1981 0.93
51 Mapping autosomal recessive vitamin D dependency type I to chromosome 12q14 by linkage analysis. Am J Hum Genet 1990 0.93
52 Mineralization in osteoblast cultures: a light and electron microscopic study. Bone 1988 0.92
53 Two hereditary defects related to vitamin D metabolism map to the same region of human chromosome 12q13-14. J Bone Miner Res 1992 0.91
54 Defective bone formation by Hyp mouse bone cells transplanted into normal mice: evidence in favor of an intrinsic osteoblast defect. J Bone Miner Res 1992 0.91
55 Bone response to phosphate and vitamin D metabolites in the hypophosphatemic male mouse. Calcif Tissue Int 1982 0.91
56 Human collagen 'fingerprints' produced by clostridopeptidase A digestion and high-pressure liquid chromatography. Biochem J 1977 0.89
57 Separation of collagen cyanogen bromide-derived peptides by reversed-phase high-performance liquid chromatography. Biochem J 1980 0.88
58 Genetic changes in the RNA components of RNase MRP and RNase P in Schmid metaphyseal chondrodysplasia. J Med Genet 2003 0.88
59 Severe osteogenesis imperfecta caused by a small in-frame deletion in CRTAP. Am J Med Genet A 2011 0.87
60 Defective bone formation by transplanted Hyp mouse bone cells into normal mice. Endocrinology 1988 0.87
61 24,25 Dihydroxyvitamin D supplementation corrects hyperparathyroidism and improves skeletal abnormalities in X-linked hypophosphatemic rickets--a clinical research center study. J Clin Endocrinol Metab 1996 0.87
62 Principles and results of corrective lower limb osteotomies for patients with vitamin D-resistant hypophosphatemic rickets. Clin Orthop Relat Res 1988 0.86
63 The microscopic structure of bone in normal children and patients with osteogenesis imperfecta: a survey using backscattered electron imaging. Calcif Tissue Int 1999 0.86
64 Osteogenesis imperfecta type VII maps to the short arm of chromosome 3. Bone 2002 0.86
65 Response to crystalline 1alpha-hydroxyvitamin D3 in vitamin D dependency. Pediatr Res 1975 0.86
66 A cross-sectional multicenter study of osteogenesis imperfecta in North America - results from the linked clinical research centers. Clin Genet 2014 0.86
67 Short- and long-term outcome of patients with pseudo-vitamin D deficiency rickets treated with calcitriol. J Clin Endocrinol Metab 2010 0.86
68 Human 25-hydroxyvitamin D 24-hydroxylase cytochrome P450 subunit maps to a different chromosomal location than that of pseudovitamin D-deficient rickets. J Bone Miner Res 1993 0.85
69 Bone turnover assessment in infants. Acta Paediatr 2000 0.85
70 Healing of bone lesions with 1,25-dihydroxyvitamin D3 in the young X-linked hypophosphatemic male mouse. Endocrinology 1982 0.85
71 [Purpura fulminans]. Can Med Assoc J 1969 0.85
72 Accuracy of measurements of small changes in soft-tissue mass by dual-energy x-ray absorptiometry. Clin Invest Med 1996 0.85
73 Early oral administration of vitamin D and its metabolites in premature neonates. Effect on mineral homeostasis. Pediatr Res 1982 0.84
74 Stimulation of cortical bone mineralization and remodeling by phosphate and 1,25-dihydroxyvitamin D in vitamin D-resistant rickets. Metab Bone Dis Relat Res 1981 0.84
75 24,25-Dihydroxyvitamin D--active metabolite or inactive catabolite? Endocrinology 1998 0.83
76 Analysis of the type of collagen present in osteoarthritic human cartilage. Clin Orthop Relat Res 1982 0.83
77 Histological osteomalacia due to dietary calcium deficiency in children. N Engl J Med 1982 0.83
78 Osteogenesis imperfecta: comparison of molecular defects with bone histological changes. Bone 1994 0.83
79 Induction of bone resorption by parathyroid hormone in congenital malignant osteopetrosis. Metab Bone Dis Relat Res 1981 0.83
80 Vitamin D metabolism in preterm infants. Serial serum calcitriol values during the first four days of life. Acta Paediatr Scand 1983 0.83
81 Quantitative immunogold labeling of bone sialoprotein and osteopontin in methylmethacrylate-embedded rat bone. J Histochem Cytochem 2003 0.83
82 Mineral balance and whole body bone mineral content in very low-birth-weight infants. Acta Paediatr Suppl 1994 0.82
83 In vitro sulfate turnover in osteogenesis imperfecta congenita and tarda. Am J Med Genet 1979 0.82
84 Single-dose pharmacokinetics and tolerability of alendronate 35- and 70-milligram tablets in children and adolescents with osteogenesis imperfecta type I. J Clin Endocrinol Metab 2005 0.82
85 Perinatal vitamin D metabolism. Biol Neonate 1988 0.82
86 Phospholipid changes in the bones of the hypophosphatemic mouse. Bone 1991 0.82
87 Temporal and spatial expression of bone morphogenetic protein-2, -4, and -7 during distraction osteogenesis in rabbits. Bone 2000 0.81
88 Abnormal response of osteoblasts from Hyp mice to 1,25-dihydroxyvitamin D3. Bone 1992 0.81
89 Kinetics of liver microsomal cholecalciferol 25-hydroxylase in vitamin D-depleted and -repleated rats. Biochem J 1978 0.81
90 Intestinal phosphate transport in familial hypophosphatemic rickets. Pediatr Res 1976 0.81
91 Identification of type I collagen gene (COL1A2) mutations in nonlethal osteogenesis imperfecta. Hum Mol Genet 1993 0.81
92 Vitamin D metabolism in preterm infants. Biol Neonate 1987 0.80
93 Perinatal serum bone Gla-protein and vitamin D metabolites in preterm and fullterm neonates. J Clin Endocrinol Metab 1987 0.80
94 A simplified assay for serum 25-hydroxycalciferol. Clin Biochem 1980 0.80
95 Effect of 1,25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice. J Bone Miner Res 1995 0.80
96 Transport and metabolism of sarcosine in hypersarcosinemic and normal phenotypes. J Clin Invest 1971 0.80
97 Bone histomorphometry in asymptomatic adults with hereditary hypophosphatemic vitamin D-resistant osteomalacia. Metab Bone Dis Relat Res 1982 0.80
98 Rickets, the continuing challenge. N Engl J Med 1991 0.80
99 Aberrant splicing of the type III procollagen mRNA leads to intracellular degradation of the protein in a patient with Ehlers-Danlos type IV. Hum Mutat 1995 0.79
100 Panostotic fibrous dysplasia. A new craniotubular dysplasia. Clin Nucl Med 1992 0.79
101 Human fetal bone development: histomorphometric evaluation of the proximal femoral metaphysis. Bone 2002 0.79
102 Effect of gene dose and parental origin on bone histomorphometry in X-linked Hyp mice. Bone 2004 0.79
103 Effects of hyperprolactinemia on calciotropic hormones. Med Biol 1980 0.78
104 Osteopathia striata with cranial sclerosis: clinical, radiological, and bone histological findings in an adolescent girl. Am J Med Genet A 2004 0.78
105 Healing of rickets with phosphate supplementation in the hypophosphatemic male mouse. J Clin Invest 1981 0.78
106 Cultured osteoblasts from normal and hypophosphatemic mice: calcitriol receptors and biological response to the hormone. Bone 1990 0.78
107 Phosphate transport by osteoblasts from X-linked hypophosphatemic mice. Am J Physiol 1994 0.78
108 Vitamin D status in breastfed term babies. Acta Paediatr 1998 0.78
109 Vitamin D metabolism in preterm infants: serum calcitriol values during the first five days of life. J Pediatr 1981 0.78
110 In vivo osteogenic activity of isolated human bone cells. J Bone Miner Res 1991 0.78
111 Assessment of bone mineral content in infants: the new age. Acta Paediatr 1993 0.78
112 Inadequate bone response to phosphate and vitamin D in familial hypophosphatemic rickets (FHR). Adv Exp Med Biol 1978 0.77
113 Histomorphometric study of bone remodeling in hypophosphatemic vitamin D-resistant rickets. Metab Bone Dis Relat Res 1981 0.77
114 Panostotic fibrous dysplasia: a congenital disorder of bone with unusual facial appearance, bone fragility, hyperphosphatasemia, and hypophosphatemia. Am J Med Genet 1983 0.76
115 Congenital primary cutaneous osteoma: biochemical and histological studies. Arch Dermatol Res 1983 0.75
116 Early diagnosis in Niemann-Pick disease. Can Med Assoc J 1974 0.75
117 X-linked hypophosphatemia: an appreciation of a classic paper and a survey of progress since 1958. Medicine (Baltimore) 1991 0.75
118 Vitamin D metabolism in preterm infants: effect of a calcium load. Biol Neonate 1988 0.75
119 [Recent advances in hepatic transplantation]. Ann Chir 1976 0.75
120 Role of the source of phosphate salt in improving the mineral balance of parenterally fed low birth weight infants. J Pediatr 1990 0.75
121 Effects of phosphate and 1,25(OH)2D3 on in vitro bone collagen synthesis in the hypophosphatemic mouse. Calcif Tissue Int 1983 0.75
122 Influence of vitamin D3 status, phenobarbital, and diphenylhydantoin treatment on the plasma 25-hydroxyvitamin D3 concentrations in the rat. Can J Physiol Pharmacol 1981 0.75
123 Renal osteodystrophy in children treated with 1,25-dihydroxy-cholecalciferol [1,25-(OH)2D3]. Histologic bone studies. Acta Paediatr Scand 1984 0.75
124 Normal serum 25-hydroxyvitamin D levels in phenobarbital-treated toddlers. Dev Pharmacol Ther 1983 0.75
125 Kinetic alterations in rat liver microsomal cholecalciferol 25-hydroxylase associated with phenobarbital administration. Biochem Pharmacol 1980 0.75
126 Simultaneous measurement of serum 25-hydroxycholecalciferol and 25-hydroxyergocalciferol. Med Biol 1979 0.75
127 Distribution of circulating immunoreactive components of parathyroid hormone in normal subjects and in patients with primary and secondary hyperparathyroidism: the role of the kidney and of the serum calcium concentration. Clin Sci (Lond) 1979 0.75
128 Letter: Parathyroid hormone secretion in X-linked hypophosphatemia. N Engl J Med 1974 0.75
129 Lethal osteogenesis imperfecta with amniotic band lesions: collagen studies. Am J Med Genet 1986 0.75
130 The collagen crosslinking in the hypophosphatemic male mouse. Calcif Tissue Int 1981 0.75